Clarivate PLC
CLVT4.290USD
+0.059+1.42%
Close 06/16, 16:00（ET）Quotes delayed by 15 min
2.93BMarket Cap
LossP/E TTM
More Details of Clarivate PLC Company
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.
Company Info
Ticker SymbolCLVT
Company nameClarivate PLC
IPO dateOct 29, 2018
Founded at2019
CEOMr. Matitiahu Shem (Matti) Tov
Number of employees12000
Security typeOrdinary Share
Fiscal year-endOct 29
Address70 St. Mary Axe
CityLONDON
Stock exchangeNYSE Consolidated
CountryUnited Kingdom
Postal codeEC3A 8BE
Phone442074334000
Websitehttps://clarivate.com/
Ticker SymbolCLVT
IPO dateOct 29, 2018
Founded at2019
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
411.80K
-8.81%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Ms. Suzanne Heywood
Ms. Suzanne Heywood
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
Mr. Mark Donohue
Mr. Mark Donohue
Vice President - Investor Relations
Vice President - Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
729.15K
+150.40%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
488.98K
+10.04%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
411.80K
-8.81%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Subscription revenues
1.63B
63.63%
Transactional revenues
500.10M
19.56%
Re-occurring revenues
429.80M
16.81%
By RegionUSD
Name
Revenue
Proportion
Americas
1.38B
54.03%
Europe/ Middle East /Africa
667.80M
26.12%
Asia Pacific
507.50M
19.85%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Subscription revenues
1.63B
63.63%
Transactional revenues
500.10M
19.56%
Re-occurring revenues
429.80M
16.81%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Leonard Green & Partners, L.P.
17.08%
Clarkston Capital Partners, LLC
10.91%
Giovanni Agnelli B V
9.85%
Impactive Capital LP
6.30%
Onex Corporation
6.14%
Other
49.72%
Shareholders
Shareholders
Proportion
Leonard Green & Partners, L.P.
17.08%
Clarkston Capital Partners, LLC
10.91%
Giovanni Agnelli B V
9.85%
Impactive Capital LP
6.30%
Onex Corporation
6.14%
Other
49.72%
Shareholder Types
Shareholders
Proportion
Private Equity
30.46%
Investment Advisor
28.17%
Investment Advisor/Hedge Fund
15.54%
Hedge Fund
14.68%
Holding Company
9.85%
Corporation
5.58%
Pension Fund
1.73%
Individual Investor
1.04%
Sovereign Wealth Fund
0.85%
Institutional Shareholding
Updated: Sat, Feb 22
Updated: Sat, Feb 22
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
677
774.53M
113.38%
-133.10M
2024Q4
712
766.77M
110.84%
-166.20M
2024Q3
726
765.53M
108.25%
-158.23M
2024Q2
741
760.08M
105.78%
-120.39M
2024Q1
752
730.14M
108.67%
-137.39M
2023Q4
783
725.50M
108.90%
-179.38M
2023Q3
791
741.16M
111.25%
-79.71M
2023Q2
796
712.25M
105.35%
-100.17M
2023Q1
777
702.68M
104.01%
-43.46M
2022Q4
788
663.31M
98.18%
-69.01M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Leonard Green & Partners, L.P.
116.67M
16.93%
--
--
Dec 31, 2024
Clarkston Capital Partners, LLC
70.73M
10.27%
-1.48M
-2.04%
Dec 31, 2024
Giovanni Agnelli B V
67.29M
9.77%
--
--
Dec 31, 2024
Impactive Capital LP
43.03M
6.25%
+3.40M
+8.58%
Dec 31, 2024
Onex Corporation
42.86M
6.22%
--
--
Mar 15, 2024
Selige Co-Investor Pooling SCSp
38.09M
5.53%
--
--
Mar 15, 2024
Partners Group AG
25.58M
3.71%
--
--
Dec 31, 2024
Cambridge Information Group, Inc.
23.61M
3.43%
--
--
Mar 15, 2024
Dimensional Fund Advisors, L.P.
14.46M
2.1%
-38.61K
-0.27%
Dec 31, 2024
Fidelity Investments Canada ULC
15.29M
2.22%
-1.75M
-10.27%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
AGF US Market Neutral Anti-Beta Fund
0.52%
First Trust Technology Alphadex
0.35%
WisdomTree US MidCap Fund
0.2%
JPMorgan US Value Factor ETF
0.19%
Avantis US Small Cap Value ETF
0.16%
John Hancock Multifactor Small Cap ETF
0.15%
Nuveen ESG Small-Cap ETF
0.15%
DFA Dimensional US Small Cap Value ETF
0.13%
T Rowe Price Small-Mid Cap ETF
0.12%
BNY Mellon US Small Cap Core Equity ETF
0.1%
View more
AGF US Market Neutral Anti-Beta Fund
Proportion0.52%
First Trust Technology Alphadex
Proportion0.35%
WisdomTree US MidCap Fund
Proportion0.2%
JPMorgan US Value Factor ETF
Proportion0.19%
Avantis US Small Cap Value ETF
Proportion0.16%
John Hancock Multifactor Small Cap ETF
Proportion0.15%
Nuveen ESG Small-Cap ETF
Proportion0.15%
DFA Dimensional US Small Cap Value ETF
Proportion0.13%
T Rowe Price Small-Mid Cap ETF
Proportion0.12%
BNY Mellon US Small Cap Core Equity ETF
Proportion0.1%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
